Detalhe da pesquisa
1.
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
Eur Heart J
; 43(39): 3947-3956, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856777
2.
Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition.
J Cardiovasc Pharmacol
; 78(4): 496-500, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173811
3.
Site qualification and clinical interpretation standards for 99mTc-SPECT perfusion imaging in a multi-center study of MITNEC (Medical Imaging Trials Network of Canada).
J Nucl Cardiol
; 28(6): 2712-2725, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32185684
4.
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib.
Am Heart J
; 222: 157-165, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087417
5.
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.
Circ Genom Precis Med
; 14(2): e003219, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794646
6.
High-density lipoprotein/apolipoprotein A-I infusion therapy.
Curr Atheroscler Rep
; 11(1): 58-63, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19080729
7.
Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease.
Nutr Rev
; 66(2): 76-81, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18254873
8.
Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib.
Clin Pharmacokinet
; 57(11): 1359-1367, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730761
9.
Vascular biomarkers and surrogates in cardiovascular disease.
Circulation
; 113(25): 2936-42, 2006 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16801474
10.
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
JAMA
; 297(15): 1675-82, 2007 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17387133
11.
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging.
J Am Coll Cardiol
; 45(4): 553-8, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15708703
12.
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Am J Cardiol
; 98(1): 23-7, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16784914
13.
Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease.
J Nucl Cardiol
; 13(6): 761-7, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17174807
14.
The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy.
Biomark Cancer
; 8(Suppl 2): 39-45, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27257396
15.
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Circulation
; 110(21): 3372-7, 2004 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15533865
16.
Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.
Atherosclerosis
; 171(2): 273-9, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14644397
17.
Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
Am Heart J
; 144(4): 589-96, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12360153
18.
Current good manufacturing practices for PET drug products in the United States.
J Nucl Med
; 50(8): 26N-8N, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19652213
19.
Acyl coenzyme A:cholesterol acyltransferase inhibition: potential atherosclerosis therapy or springboard for other discoveries?
Expert Opin Investig Drugs
; 11(11): 1519-27, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12437499
20.
Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network.
Can J Cardiol
; 29(3): 297-303, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23245557